Myostatin Dystrophie myotonique Myotonic Dystrophy Type 1 Brain dysfunction GABA Glucocorticoids Gene editing Dystrophin Expression Acute coronary syndrome Muscular dystrophy In vivo RNA splicing Centronuclear myopathy Genotype phenotype correlation Hypoxia PCR Alternative splicing Cell penetrating peptide Humans CTG repeats CONGENITAL MYATHENIC SYNDROME Intermediate filament BIOLOGIE MOLECULAIRE Duchenne muscular dystrophy ARN Endurance training CRISPRi RNA interference Oligodendrocytes Myotonic Dystrophy type 1 MBNL Myotonic dystrophy Cardiac muscle Dynamin 2 Transgenic mouse Fibrosis Dystrophie Myotonique Cytoskeleton Gene Therapy CRISPR/Cas9 Glucocorticoid-receptor Trinucleotide Repeat Expansion CTG repeat instability Trinucleotide repeat expansion Glial cells Maximal force AAV Myotonic dystrophy type 1 Diaphragm Heart Cell culture model CTG repeat contractions Antisense oligonucleotide Knockout Gene therapy DMPK Mice RNA biology Muscle Glutamate Myelin Dilated cardiomyopathy Antisense oligonucleotides Transgenic mouse model Exercice Aging DMSXL mice Autophagy CMS Transcriptomics Heart failure Acetylcholinesterase knockout mouse Mouse model Animals Brain Exercise Thérapie génique Mouse models Long read sequencing DM1 Quantitative microdialysis Astrocytes Astrocyte Oligodendrocyte Myotonic dystrophy mouse models KNOCKOUT MICE GSK3␤ Skeletal muscle Central nervous system Neuron Therapy ACETYLCHOLINESTERASE Male PacBio Desmin Cell model Motoneuron Acetylcholinesterase deficiency Myotonic Dystrophy